Service de Néphrologie Pédiatrique, Centre de référence Marhea, Hôpital Necker-Enfants malades, Assistance Publique-Hôpitaux de Paris, Paris, France.
Université de Paris, Institut Necker-Enfants Malades Inserm U1151, Paris, France.
Pediatr Nephrol. 2021 Oct;36(10):3159-3168. doi: 10.1007/s00467-021-05074-z. Epub 2021 Apr 25.
A precise assessment of glomerular filtration rate is key to delineate the care of children with a solitary functioning kidney (SFK). Data regarding measured GFR (mGFR) in this population is restricted to a single study of 77 individuals, which suggested that a GFR estimation (eGFR) method based on creatinine and cystatin C (eGFR-CKiD2) performed better than Schwartz's equation (eGFR-Schwartz).
We measured GFR in 210 consecutive adolescents (7 to 22 years old) with an SFK referred to our institution between 2014 and 2019 and in 43 young candidates for kidney donation (18 to 25 years old). We compared the distribution of mGFR in both groups and determined the factors associated with reduced mGFR in adolescents with an SFK. We further compared different eGFR formulas with mGFR and assessed the association of mGFR and eGFRs with PTH and FGF23, two early indicators of GFR reduction.
While adolescents with an SFK had a similar median mGFR to healthy controls (103 ± 24ml/min/1.73m vs. 107 ± 12 ml/min/1.73m), the fraction of individuals with an mGFR below 90 ml/min/1.73m was higher in patients with SFK (23% vs. 5% in controls; P = 0.005). Multiple linear regression identified older age, ipsilateral abnormalities of the urinary tract, lack of compensatory hypertrophy, and treated hypertension as independent factors associated with reduced mGFR. A smaller bias using eGFR-Schwartz (95% confidence interval (95%CI): 3 to 7) was revealed when compared to other eGFR. Compared to eGFR-Schwartz, mGFR showed a stronger correlation with PTH (r = 0.04 vs. r = 0.1) and FGF23 (r = 0.03 vs. r = 0.05).
SFK is not a benign condition, since 20% of the patients display altered kidney function. Our results raise caution regarding the use of the cystatin-based equation. mGFR shows a better ability than eGFR-Schwartz to differentiate patients showing early homeostatic adaptation to GFR reduction.
准确评估肾小球滤过率对于明确孤立肾(SFK)患儿的治疗至关重要。目前,有关该人群的实测肾小球滤过率(mGFR)的数据仅限于一项针对 77 例患者的研究,该研究表明基于肌酐和胱抑素 C 的肾小球滤过率估计(eGFR-CKiD2)方法优于 Schwartz 方程(eGFR-Schwartz)。
我们测量了 2014 年至 2019 年期间我院收治的 210 例连续的 SFK 青少年(7 至 22 岁)和 43 例年轻的肾脏供体候选者(18 至 25 岁)的肾小球滤过率。我们比较了两组 mGFR 的分布,并确定了 SFK 青少年中与 mGFR 降低相关的因素。我们还比较了不同的 eGFR 公式与 mGFR,并评估了 mGFR 和 eGFR 与甲状旁腺激素(PTH)和成纤维细胞生长因子 23(FGF23)的相关性,这两个都是肾小球滤过率降低的早期指标。
SFK 青少年的 mGFR 中位数与健康对照组相似(103 ± 24ml/min/1.73m 与 107 ± 12 ml/min/1.73m),但 SFK 患者中 mGFR 低于 90 ml/min/1.73m 的患者比例更高(23%比对照组的 5%;P = 0.005)。多元线性回归分析发现,年龄较大、同侧尿路异常、缺乏代偿性肥大和治疗性高血压是与 mGFR 降低相关的独立因素。与其他 eGFR 相比,使用 eGFR-Schwartz 时的偏差更小(95%置信区间(95%CI):3 至 7)。与 eGFR-Schwartz 相比,mGFR 与 PTH(r = 0.04 与 r = 0.1)和 FGF23(r = 0.03 与 r = 0.05)的相关性更强。
SFK 并不是一种良性疾病,因为 20%的患者存在肾功能改变。我们的结果表明,在使用胱抑素基方程时需要谨慎。mGFR 比 eGFR-Schwartz 更能区分显示肾小球滤过率降低的早期体内平衡适应的患者。